Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Videos | ACC | March 21, 2018

DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at the 2018...

Statins May Bring Benefits at Time of Treatment for Heart Attack, Angina

Image from presentation, "Statins Evaluation in Coronary Procedures and Revascularization," Berwanger 

News | ACC | March 20, 2018

March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a...

Ticagrelor Has Comparable Safety to Clopidogrel after Heart Attack

Image from presentation, "Ticagrelor Versus Clopidogrel After Thrombolytic Therapy in Patients With St-Elevation Myocardial Infarction: A Randomized Clinical Trial," Berwanger 

News | ACC | March 20, 2018

March 20, 2018 — Among people younger than 75 years who were given clot busters to treat a heart attack, taking the...

Edwards Lifesciences received European CE mark clearance for its self-expanding Centera transcatheter aortic valve replacement (TAVR) device for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery.

Edwards Lifesciences received European CE mark clearance for its self-expanding Centera transcatheter aortic valve replacement (TAVR) device for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery. This was the top structural heart story of the month of February 2018.

Feature | March 20, 2018 | Dave Fornell

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC)...

Trial Bolsters Evidence in Favor of Closing Hole in Heart After Stroke
News | ACC | March 20, 2018

March 20, 2018 — Among people with a type of hole in the heart, known as patent foramen ovale (PFO), those who...

The largest trial to date for short-term DAPT concluded the practice cannot be deemed safe due to a higher adverse event rate. Image courtesy of the American Heart Association. #ACC18

The largest trial to date for short-term DAPT concluded the practice cannot be deemed safe due to a higher adverse event rate. Image courtesy of the American Heart Association.

News | Antiplatelet and Anticoagulation Therapies | March 19, 2018

March 19, 2018 — The combined rate of death from any cause, heart attack or stroke within 18 months was not...

Videos | Cath Lab | March 15, 2018

A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical...

Videos | Heart Valve Technology | March 15, 2018

Insights from the STS/ACC TVT Transcatheter Valve Registry, presented at the American College of Cardiology (ACC)...

Videos | FFR Technologies | March 15, 2018

An economic analysis of the DEFINE-FLAIR study comparing FFR vs. iFR, found a cost savings of nearly $900. The late-...

The Xarelto booth at ACC.18

The Xarelto booth at the 2018 American College of Cardiology meeting. 

News | Antiplatelet and Anticoagulation Therapies | March 14, 2018

March 14, 2018 — A late-breaking analysis of the landmark COMPASS study presented at the American College of...

Videos | Sudden Cardiac Arrest | March 14, 2018

The Zoll LifeVest is a temporary, wearable defibrillator designed as a safety net for patients, especially those...

Infraredx Highlights Value of IVUS + NIRS for Detecting Lipid Core Plaque at ACC.18
News | Intra-Vascular Ultrasound (IVUS) | March 13, 2018

March 13, 2018 –  Infraredx, a company that works in...

CoreValve TAVR System Shows Strong Long-Term Performance in Clinical Trials
News | Heart Valve Technology | March 12, 2018

March 12, 2018 — Medtronic plc unveiled outcomes from the CoreValve U.S. Pivotal Extreme Risk Study and the real-...

iFR More Cost-Effective Than FFR in PCI Guidance
News | FFR Technologies | March 12, 2018

March 12, 2018 — Philips announced health economic results from the DEFINE FLAIR clinical trial comparing cost-...

Overlay Init